WO2002004601A3 - Mammalian mdm2 binding proteins and uses thereof - Google Patents

Mammalian mdm2 binding proteins and uses thereof Download PDF

Info

Publication number
WO2002004601A3
WO2002004601A3 PCT/US2001/022053 US0122053W WO0204601A3 WO 2002004601 A3 WO2002004601 A3 WO 2002004601A3 US 0122053 W US0122053 W US 0122053W WO 0204601 A3 WO0204601 A3 WO 0204601A3
Authority
WO
WIPO (PCT)
Prior art keywords
mdm2 binding
mammalian mdm2
binding protein
mammalian
binding proteins
Prior art date
Application number
PCT/US2001/022053
Other languages
French (fr)
Other versions
WO2002004601A2 (en
Inventor
Mark Thomas Boyd
Dale Stewart Haines
Nikolina Vlatkovic
Original Assignee
Philadelphia Health & Educatio
Mark Thomas Boyd
Dale Stewart Haines
Nikolina Vlatkovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health & Educatio, Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic filed Critical Philadelphia Health & Educatio
Priority to AU2001276899A priority Critical patent/AU2001276899A1/en
Priority to US10/312,954 priority patent/US7166712B2/en
Publication of WO2002004601A2 publication Critical patent/WO2002004601A2/en
Publication of WO2002004601A3 publication Critical patent/WO2002004601A3/en
Priority to US11/650,159 priority patent/US7304142B2/en
Priority to US11/876,901 priority patent/US7732577B2/en
Priority to US12/759,906 priority patent/US20100286362A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
PCT/US2001/022053 2000-07-12 2001-07-12 Mammalian mdm2 binding proteins and uses thereof WO2002004601A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2001276899A AU2001276899A1 (en) 2000-07-12 2001-07-12 Mammalian mdm2 binding proteins and uses thereof
US10/312,954 US7166712B2 (en) 2000-07-12 2001-07-12 Mammalian MDM2 binding proteins and uses thereof
US11/650,159 US7304142B2 (en) 2000-07-12 2007-01-05 Mammalian MDM2 binding proteins
US11/876,901 US7732577B2 (en) 2000-07-12 2007-10-23 Isolated antibody specific for a mammalian MDM2 binding protein comprising SEQ ID No. 2 or 4
US12/759,906 US20100286362A1 (en) 2000-07-12 2010-04-14 Mammalian MDM2 Binding Proteins and Uses Thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21783500P 2000-07-12 2000-07-12
US60/217,835 2000-07-12
US23089400P 2000-09-05 2000-09-05
US60/230,894 2000-09-05

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10312954 A-371-Of-International 2001-07-12
US11/650,159 Division US7304142B2 (en) 2000-07-12 2007-01-05 Mammalian MDM2 binding proteins

Publications (2)

Publication Number Publication Date
WO2002004601A2 WO2002004601A2 (en) 2002-01-17
WO2002004601A3 true WO2002004601A3 (en) 2002-06-27

Family

ID=26912305

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022053 WO2002004601A2 (en) 2000-07-12 2001-07-12 Mammalian mdm2 binding proteins and uses thereof

Country Status (2)

Country Link
AU (1) AU2001276899A1 (en)
WO (1) WO2002004601A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012294A (en) * 2004-04-22 2007-03-15 Johnson & Johnson Hdm2-inhibitor complexes and uses thereof.
GB0428187D0 (en) * 2004-12-23 2005-01-26 Univ Liverpool Cancer treatment
WO2022240757A1 (en) 2021-05-10 2022-11-17 Entrada Therapeutics, Inc. Antigen-binding and antigen degradation constructs

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOYD ET AL.: "A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 14, 13 October 2000 (2000-10-13), pages 31883 - 31890, XP002908459 *
JUVEN-GERSHON ET AL.: "The MDM2 oncoprotein interacts with the cell fate regulator numb.", MOLECULAR AND CELLULAR BIOLOGY, vol. 18, no. 7, July 1988 (1988-07-01), pages 3974 - 3982, XP001031399 *
SHARP ET AL.: "Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 53, 31 December 1999 (1999-12-31), pages 38189 - 38196, XP002908461 *
VLATKOVIC ET AL.: "A novel MDM2 binding protein (MTBP) induces a G1 arrest that is suppressed by MDM2", BRITISH J. CANCER, vol. 83, no. 3A, 11 July 2000 (2000-07-11), pages 60, XP002908460 *

Also Published As

Publication number Publication date
AU2001276899A1 (en) 2002-01-21
WO2002004601A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
WO2001075087A3 (en) Subtilisin variants
WO1999066025A3 (en) Mtbx protein and nucleic acid molecules and uses therefor
WO2002006457A3 (en) Novel lipase genes
WO1999061469A3 (en) Prostate growth-associated membrane proteins
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
WO2004024750A3 (en) Cd44-binding ligands
BR0009393A (en) Polypeptide, isolated nucleic acid sequence, nucleic acid construct, recombinant expression vector, recombinant host cell, method for producing polypeptide, use of polypeptide, and detergent composition
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2002036627A3 (en) Interferons, uses and compositions related thereto
WO2000075358A3 (en) Mammalian toll homologues and uses thereof
WO2001073028A3 (en) A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
WO2002004601A3 (en) Mammalian mdm2 binding proteins and uses thereof
WO2000012544A3 (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
DE59712771D1 (en) Epididymis-specific receptor protein and its use
WO2001077151A3 (en) Fdrg proteins and nucleic acid molecules and uses therefor
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2000027874A3 (en) Nucleic acids encoding transferrin receptor-like proteins and products related thereto
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2000068376A8 (en) Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
WO2001083523A3 (en) Stmst protein and nucleic acid molecules and uses therefor
WO2001036476A3 (en) Ing2, an iaps associated cell cycle protein, compositions and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10312954

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP